Promoter Specificity and Biological Activity of Tethered AP-1 Dimers
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Activator protein 1 (AP-1) is a group of dimeric transcription factors composed of Jun, Fos, and ATF family proteins. Both gain- and loss-of-function studies have revealed specific roles for individual AP-1 components in cell proliferation, differentiation, apoptosis, and other biological processes. However, little is known about the functions of specific AP-1 dimers. To test the importance of AP-1 composition in transcriptional activation, AP-1 monomers were joined via a flexible polypeptide tether to force specific pairing. The resultant single-chain AP-1 molecules showed DNA binding specificity and transcriptional activation potentials similar to those of untethered dimers, even in the presence of dominant-negative AP-1 monomers. c-Jun-containing dimers showed distinct promoter specificity in transient-transfection experiments, depending on the Fos, Fra, or ATF partner. When stably expressed in NIH 3T3 cells, c-Jun tethered dimer Fra2, but not c-Jun tethered dimer Fra1 and c-Jun tethered dimer cFos (the tilde indicates a tethered dimer), inhibited G(0) arrest at confluency and under low-serum conditions and specifically activated cyclin A expression. These data suggest that the choice of dimerization partner defines the role of c-Jun in gene activation and cell cycle regulation and that single-chain AP-1 molecules provide a powerful tool for assessing the role of specific AP-1 dimers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443 · cited 1×
“The bZIP motif consists of a DNA-binding domain rich in basic amino acids and an adjacent protein-protein dimerization domain known as the leucine zipper structure, which is characterized by leucines at every seventh residue (21).”
BackgroundMechanism of specificity in the Fos-Jun oncoprotein heterodimer
O'Shea, E. K., Rutkowski, R., & Kim, P. S. (1992) · Cell · doi:10.1016/0092-8674(92)90145-3 · Cited by 422
A Mechanism for Translationally Coupled mRNA Turnover
Grosset, C., Chen, C.-Y. A., Xu, N., Sonenberg, N., Jacquemin-Sablon, H., & Shyu, A.-B. (2000) · Cell · doi:10.1016/s0092-8674(00)00102-1 · Cited by 295
Structure-Based Design of Transcription Factors
Pomerantz, J. L., Sharp, P. A., & Pabo, C. O. (1995) · Science · doi:10.1126/science.7809612 · Cited by 226 · cited 1×
“it more disruptive than dimerization domain swapping or mutagenesis in order to restrict dimerization to one or more partners (1, 4, 31, 37).”
Background
Cited by
AP-1: a double-edged sword in tumorigenesis
Eferl, R., & Wagner, E. F. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1209 · Cited by 2,242
Self-citationTranscriptional regulation by calcium, calcineurin, and NFAT
Hogan, P. G., Chen, L., Nardone, J., & Rao, A. (2003) · Genes & Development · doi:10.1101/gad.1102703 · Cited by 1,991
“With the advent of new reagents (“tethered AP-1” dimers; Bakiri et al. 2002), constitutively active NFAT proteins (Macián et al.”
BackgroundAP-1 subunits: quarrel and harmony among siblings
Hess, J., Angel, P., & Schorpp-Kistner, M. (2004) · Journal of Cell Science · doi:10.1242/jcs.01589 · Cited by 1,302
Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
Zanconato, F., Forcato, M., Battilana, G., Azzolin, L., Quaranta, E., Bodega, B., Rosato, A., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2015) · Nature Cell Biology · doi:10.1038/ncb3216 · Cited by 1,219
Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy
Manabe, I., Shindo, T., & Nagai, R. (2002) · Circulation Research · doi:10.1161/01.res.0000046452.67724.b8 · Cited by 512
Cardiac fibroblasts: friend or foe?
Baudino, T. A., Carver, W., Giles, W., & Borg, T. K. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00023.2006 · Cited by 427
“Furthermore, AP-1 binding sites have been identified in the promoter regions of numerous genes, including transcription factors, ECM proteins, MMPs, cell adhesion molecules, growth factors, cytokines, and cyclins (9).”
Distinct Roles for JNK1 and JNK2 in Regulating JNK Activity and c-Jun-Dependent Cell Proliferation
Sabapathy, K., Hochedlinger, K., Nam, S. Y., Bauer, A., Karin, M., & Wagner, E. F. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.028 · Cited by 396
Self-citationAllenspach, E. J., Maillard, I., Aster, J. C., & Pear, W. S. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.1.5.159 · Cited by 344
Woetzel, D., Huber, R., Kupfer, P., Pohlers, D., Pfaff, M., Driesch, D., Häupl, T., Koczan, D., Stiehl, P., Guthke, R., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4526 · Cited by 276
Mitogen-Activated Protein Kinase Pathways in Osteoblasts
Greenblatt, M. B., Shim, J.-H., & Glimcher, L. H. (2013) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122347 · Cited by 253
An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation
Talotta, F., Cimmino, A., Matarazzo, M. R., Casalino, L., De Vita, G., D'Esposito, M., Di Lauro, R., & Verde, P. (2009) · Oncogene · doi:10.1038/onc.2008.370 · Cited by 242
“We also analysed the PDCD4 inhibitory activity toward the ectopically expressed c-Jun/Fra-1-tethered heterodimer (Bakiri et al., 2002).”
BackgroundFRA-1 expression level regulates proliferation and invasiveness of breast cancer cells
Belguise, K., Kersual, N., Galtier, F., & Chalbos, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208312 · Cited by 220
Karaoz, E., Aksoy, A., Ayhan, S., Sarıboyacı, A. E., Kaymaz, F., & Kasap, M. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0629-6 · Cited by 210
“Particularly, c-fos has been associated with the coordinated regulation of gene expression during cellular proliferation and differentiation (Stachowiak et al. 1990; Bakiri et al. 2002).”
BackgroundThe Role of Activator Protein-1 (AP-1) Family Members in CD30-Positive Lymphomas
Garces de los Fayos Alonso, I., Liang, H.-C., Turner, S., Lagger, S., Merkel, O., & Kenner, L. (2018) · Cancers · doi:10.3390/cancers10040093 · Cited by 169
“Thus, the dimerization partners of JUN influence its role in gene activation and cell cycle regulation [11,12].”
BackgroundAP-1/c-Jun transcription factors: Regulation and function in malignant melanoma
Kappelmann, M., Bosserhoff, A., & Kuphal, S. (2014) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2013.10.003 · Cited by 162
Regulation of senescence and the SASP by the transcription factor C/EBPβ
Salotti, J., & Johnson, P. F. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110752 · Cited by 103
Cai, D. H., Wang, D., Keefer, J., Yeamans, C., Hensley, K., & Friedman, A. D. (2008) · Oncogene · doi:10.1038/sj.onc.1210940 · Cited by 96
“To assess the function of specific bZIP homodimers or heterodimers, one group linked Jun and Fos proteins via an 18 amino acid tether (Bakiri et al 2002).”
BackgroundKuzniewska, B., Rejmak, E., Malik, A. R., Jaworski, J., Kaczmarek, L., & Kalita, K. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00008-13 · Cited by 82
Function of JunB in transient amplifying cell senescence and progression of human prostate cancer.
Konishi, N., Shimada, K., Nakamura, M., Ishida, E., Ota, I., Tanaka, N., & Fujimoto, K. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4120 · Cited by 46
Zoumi, A., Datta, S., Liaw, L.-H. L., Wu, C. J., Manthripragada, G., Osborne, T. F., & LaMorte, V. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.8.2946-2956.2005 · Cited by 10
Metadata
- Authors
- Bakiri, L., Matsuo, K., Wisniewska, M., Wagner, E. F., & Yaniv, M.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2002-07-01
- Volume
- 22
- Issue
- 13
- Pages
- 4952-4964
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2012013049
- Cited by
- 206
- References
- 5
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.